Morning Seminar April 16, 2009

Bone Marrow Transplant. 2008 Jun;41 Suppl 2:S96-9.
Haematopoietic SCT in autoimmune diseases in children: rationale and new perspectives.
abusin M, Andolina M, Maximova N; EBMT Paediatric, Autoimmune Diseases Working Parties.

Morning Seminar April 14, 2009

Leukemia. 2007 Nov;21(11):2258-63.
Outcome of risk-based therapy for infant acute lymphoblastic leukemia with or without an MLL gene rearrangement, with emphasis on late effects: a final report of two consecutive studies, MLL96 and MLL98, of the Japan Infant Leukemia Study Group.
Tomizawa D, Koh K, Sato T, Kinukawa N, Morimoto A, Isoyama K, Kosaka Y, Oda T, Oda M, Hayashi Y, Eguchi M, Horibe K, Nakahata T, Mizutani S, Ishii E.

Blood. 2004 Dec 1;104(12):3527-34.
Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation.
Kosaka Y, Koh K, Kinukawa N, Wakazono Y, Isoyama K, Oda T, Hayashi Y, Ohta S, Moritake H, Oda M, Nagatoshi Y, Kigasawa H, Ishida Y, Ohara A, Hanada R, Sako M, Sato T, Mizutani S, Horibe K, Ishii E.

Blood. 2006 Feb 1;107(3):1238-9.
KIR-incompatible hematopoietic-cell transplantation for poor prognosis infant acute lymphoblastic leukemia.
Triplett B, Handgretinger R, Pui CH, Leung W.

Morning Seminar April 9, 2009

Bone Marrow Transplant. 2009 Mar;43(6):461-8.
Health-related quality of life in adult survivors after paediatric allo-SCT.
Löf CM, Winiarski J, Giesecke A, Ljungman P, Forinder U.

Morning Seminar April 7, 2009

Blood. 2009 Mar 26;113(13):2888-94.
Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.
Mielcarek M, Storer BE, Boeckh M, Carpenter PA, McDonald GB, Deeg HJ, Nash RA, Flowers ME, Doney K, Lee S, Marr KA, Furlong T, Storb R, Appelbaum FR, Martin PJ.